These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 18888)

  • 1. Interaction of dopaminergic and cholinergic neurons in the extrapyramidal and limbic systems.
    Bartholini G; Stadler H; Gadea-Ciria M; Lloyd KG
    Adv Biochem Psychopharmacol; 1977; 16():391-5. PubMed ID: 18888
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine-acetylcholine-GABA neuronal linkages in the extrapyramidal and limbic systems.
    McGeer PL; McGeer EG; Hattori T
    Adv Biochem Psychopharmacol; 1977; 16():397-402. PubMed ID: 329651
    [No Abstract]   [Full Text] [Related]  

  • 3. Interactions between GABA, dopamine, acetylcholine, and glutamate-containing neurons in the extrapyramidal and limbic systems.
    Bartholini G; Scatton B; Worms P; Zivkovic B; Lloyd KG
    Adv Biochem Psychopharmacol; 1981; 30():119-28. PubMed ID: 6120626
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of dopaminergic activity in the extrapyramidal and limbic systems by gamma-acetylenic GABA [proceedings].
    Huot S; Lippert B; Palfreyman MG; Schechter PJ
    Br J Pharmacol; 1977 Jun; 60(2):264P-265P. PubMed ID: 880435
    [No Abstract]   [Full Text] [Related]  

  • 5. [Recent data on the mode of action of neuroleptics].
    Bartholini G
    Actual Pharmacol (Paris); 1978; 30():35-47. PubMed ID: 28640
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute and chronic treatment with neuroleptics: similarities and differences in their action on nigrostriatal, mesolimbic, and mesocortical dopaminergic neurons.
    Julou L; Scatton B; Glowinski J
    Adv Biochem Psychopharmacol; 1977; 16():617-24. PubMed ID: 18904
    [No Abstract]   [Full Text] [Related]  

  • 7. The dopamine hypothesis of schizophrenia and the antagonistic action of neuroleptic drugs--a review.
    Sayed Y; Garrison JM
    Psychopharmacol Bull; 1983; 19(2):283-8. PubMed ID: 6135238
    [No Abstract]   [Full Text] [Related]  

  • 8. Preferential effect of noncataleptogenic neuroleptics on mesolimbic dopaminergic function.
    Bartholini G
    Adv Biochem Psychopharmacol; 1977; 16():607-11. PubMed ID: 18902
    [No Abstract]   [Full Text] [Related]  

  • 9. Functions of dopamine in the extrapyramidal and limbic systems. Clues for the mechanism of drug actions.
    Di Chiara G; Morelli M; Acquas E; Carboni E
    Arzneimittelforschung; 1992 Feb; 42(2A):231-7. PubMed ID: 1586394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the new gamma-aminobutyric acid agonist SL 76 002 on striatal acetylcholine: relation to neuroleptic-induced extrapyramidal alterations.
    Bartholini G; Scatton B; Zivkovic B
    Adv Biochem Psychopharmacol; 1980; 24():207-13. PubMed ID: 6105775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interelationships between dopaminergic and cholinergic systems in the cerebral cortex.
    Mantovani P; Bartolini A; Pepeu G
    Adv Biochem Psychopharmacol; 1977; 16():423-7. PubMed ID: 883550
    [No Abstract]   [Full Text] [Related]  

  • 12. Cholinergic pathways.
    Shute CC; Lewis PR
    Pharmacol Ther B; 1975; 1(1):79-87. PubMed ID: 772701
    [No Abstract]   [Full Text] [Related]  

  • 13. The importance of the ascending dopaminergic systems to the extrapyramidal and mesolimbic brain areas for the cataleptic action of the neuroleptic and cholinergic agents.
    Costall B; Naylor RJ
    Neuropharmacology; 1974 May; 13(5):353-64. PubMed ID: 4607196
    [No Abstract]   [Full Text] [Related]  

  • 14. Behavioral implications of dopaminergic neurons in the mesolimbic system.
    Iversen SD; Koob GF
    Adv Biochem Psychopharmacol; 1977; 16():209-14. PubMed ID: 560790
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antipsychotic drug modification of motor hyperactivity and stereotyped behavior induced by amphetamine in rats with lesions in the nigrostriatal and mesolymbic dopaminergic systems].
    Sánchez-Blázquez P; Fernández-Tomé MP; Fuentes JA; del Río J
    Arch Farmacol Toxicol; 1978 Apr; 4(1):66-8. PubMed ID: 29574
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cholinergic pathways of the central nervous system (author's transl)].
    Nistri A
    Riv Patol Nerv Ment; 1974 Aug; 95(4):203-14. PubMed ID: 4470242
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
    Gygi SP; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1994 Jul; 270(1):192-7. PubMed ID: 7913495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central monoaminergic pathways with emphasis on their relation to the so called 'extrapyramidal motor system'.
    Fuxe K; Hökfelt T; Olson L; Ungerstedt U
    Pharmacol Ther B; 1977; 3(2):169-210. PubMed ID: 413120
    [No Abstract]   [Full Text] [Related]  

  • 19. Cholinergic synapses in the limbic system and behavioral inhibition.
    Grossman SP
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():315-26. PubMed ID: 4341951
    [No Abstract]   [Full Text] [Related]  

  • 20. Serotonergic-dopaminergic interactions and extrapyramidal function.
    Chase TN
    Adv Biochem Psychopharmacol; 1974; 11(0):377-85. PubMed ID: 4367649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.